Yueer Gene
Yangpu
About Yueer Gene
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2022)
- Website: carriergene.com
- Phone: 400-999-8036
Industries & Categories
Big Data, Genetics, Health Care, Medical
Canonical: https://fsome.com/organization/yueer-gene-48579 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.